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ABSTRACT  Acanthamoeba myosin-II  forms filaments  of two different  sizes. Thin  bipolar fila- 
ments 7 nm wide  and 200 nm  long consist of 16 myosin-II  molecules.  Thick bipolar filaments 
of variable width  (14-19  nm)  consist of 40 or more  myosin-II  molecules.  Both  have a central 
bare zone 90 nm long and myosin heads projecting laterally at the ends. The heads are arranged 
in rows spaced  15 nm apart. In the case of the thin myosin-II filaments there are two molecules 
per  row.  The  thick  filaments  are  formed  rapidly  and  reversibly  in  the  presence  of 6-10  mM 
MgCI2  (or any of five other different  divalent cations tested)  by the lateral aggregation  of thin 
myosin-II  filaments.  Acid  pFI  also  favors  thick  filament  formation.  Neither  the  myosin-II 
concentration  (50-1,000/~g/ml)  nor ATP has an effect on the morphology of the filaments. The 
polymerization  mechanism  was  studied  quantitatively  by  measuring  the  amount  of  polymer 
formed  (Cp) under various conditions as a function of total myosin-II concentration  (G). Above 
a critical  concentration  of  15-40/~g/ml,  Cp was  proportional  to  G  with  a slope  of 0.5-0.95 
depending  on  conditions.  In  the  range  of  0.8-4.9  heavy  chain  phosphates  per  molecule, 
phosphorylation  has no effect on the morphology of either the thin or thick myosin-II filaments 
and only a small effect on the extent of polymerization. 
The polymerization of myosin into bipolar filaments has long 
been  studied  as  a  classic  example  of macromolecular  self- 
assembly (17,  18,  19) and has recently attracted new interest 
for two reasons. First, recent evidence that light chain (23, 32, 
34) and heavy chain (21) phosphorylation can modify polym- 
erization  has  led  to  speculation  that  filament  assembly  and 
disassembly  might contribute  to the  control of motile  force 
generation,  especially  in  nonmuscle  cells.  Second,  electron 
microscopy  of  nonmuscle  cells  has  failed  to  demonstrate 
myosin filaments  even  with  the  aid of ferritin-labeled  anti- 
bodies  05,  36).  Although  the  apparent  absence  of myosin 
filaments could be the result of fixation problems, this obser- 
vation  suggests  that  the  myosin  of nonmuscle  cells  is  not 
permanently in the form of filaments. 
One approach to learning how a cell regulates myosin po- 
lymerization, is to characterize the mechanism by which puri- 
fied  myosin  forms  filaments  under  well-defined  conditions. 
Elegant quantitative  studies of the polymerization of striated 
muscle myosin (9,  10,  18,  19, 30) have established that under 
the  conditions  in  which  quantitative  measurements  can  be 
made by sedimentation  velocity ultracentrifugation  (alkaline 
pH and relatively high ionic strength), skeletal muscle myosin 
forms filaments by a condensation-polymerization mechanism 
like actin and flagellin. Above a critical concentration a con- 
stunt monomer concentration is in equilibrium with any con- 
centration of polymer. The critical concentration depends on 
the salt concentration, pH, and hydrostatic pressure.  Smooth 
muscle myosin polymerization is sensitive to the same solution 
conditions, but it does not exhibit a critical concentration and 
the concentration of monomer varies with total protein concen- 
tration  (25).  The theoretical basis of this behavior is not yet 
understood. Previous studies of cytoplasmic myosin polymeri- 
zation have emphasized filament structure and simple quanti- 
tative analysis of the ionic conditions which support polymer- 
ization (3, 4,  16, 23, 26, 27, 32). It is not known, for example, 
whether cytoplasmic myosins use a condensation polymeriza- 
tion or some other mechanism of assembly. 
Of the various cytoplasmic myosins one might use in assem- 
bly  studies,  Acanthamoeba  myosin-II has  some  advantages. 
More is known about its physical properties (29) immunochem- 
istry and  enzymatic activity (6-8,  12,  13,  20,  24)  than  most 
other cytoplasmic myosins. It consists of two 175,000 molecular 
weight heavy chains and three or four light chains. It has two 
heads and a tail ~90 nm long. Compared with other myosins, 
the  tail  is  shorter  by  one-third  and  the  heavy  chains  are 
correspondingly smaller.  Myosin-II can be isolated with  1-3 
heavy chain phosphates per molecule and the actin-activated 
ATPase  activity  is  inversely  proportional  to  the  extent  of 
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heavy chain phosphates at three different sites up to a total of 
six phosphates per molecule (8).  All of these phosphates are 
thought to be located within 5 nm of the end of the myosin-II 
tail (5). 
Myosin-II forms very small bipolar filaments consisting of 
12-16 molecules (29). These filaments are unique because the 
bare zone is only 100 nm long like the myosin-II tail. All other 
myosin filaments have bare zones  150  nm long.  In the first 
study of myosin-II filaments it was noted that the filaments 
were  much  thicker under  some  conditions, such  as  10  mM 
CaC12  (29).  Furthermore,  Collins and  Korn (7)  showed that 
MgCI2 in the range of 6-7 mM  increased the  sedimentation 
rate of very low (<20 gg/ml) concentrations of both phospho- 
rylated and partially dephosphorylated myosin-II, 
The very small size of the myosin-II filaments suggests that 
the assembly mechanism might be more amenable to quanti- 
tative analysis than  that  of larger myosin filaments. For ex- 
ample,  muscle  myosin  polymerization can  only  be  studied 
quantitatively under rather restricted, nonphysiological condi- 
tions in which the filaments are relatively small. 
The  goals  of  this  study  were  to  define  the  structure  of 
myosin-II filaments by electron microscopy and to study their 
mechanism of assembly looking for possible effects of heavy 
chain phosphorylation. Myosin-II forms thin bipolar filaments 
composed of 16 molecules with the heads arranged in rows 15 
nm  apart  and  anchored  to  the  backbone  by  a  very  short 
segment  of the  tail.  These  thin  filaments  can  rapidly  and 
reversibly aggregate laterally to  form  thicker filaments.  The 
critical concentration  for  myosin-II polymerization is much 
lower than  for skeletal muscle myosin due,  perhaps,  to  the 
small size of the myosin-II filaments. Heavy chain phospho- 
rylation in the range of 0.8-4.9 phosphates per molecule has a 
relatively minor effect on the polymerization process. 
MATERIALS  AND  METHODS 
Acanthamoeba myosin-II was purified as described by Pollard et al. (29) or by a 
similar procedure omitting the low ionic strength extraction of the actomyosin 
precipitate.  Samples  from four different preparations were dephosphorytated 
with  potato  alkaline  phosphatase  (Sigma  Chemical  Co.,  St.  Louis,  MO)  as 
described by Collins and Korn (7). The reaction was carried out for 3½ to 5 h at 
30°C. The phosphate content myosin-lI was measured by a  malachite green 
assay on samples washed with trichloroacetic acid and ashed in Mg(NOa)2 (33). 
Myosin-lI filaments were formed by dialysis of soluble myosin in 0.5 M KCI, 
10 mM imidazole, pH 7 against various buffers. Sample volumes were 50-300 
#1. The bags had a flat width of 0.5 cm and the samples were small enough that 
the internal solution was < 1 mm thick. Under these conditions the half time for 
dialysis of KC1 is ~4 rain. In both electron microscopic and quantitative studies 
it is important to analyze the samples soon after removing salt to polymerize the 
filaments, because of time-dependent, at least partially irreversible, formation of 
large head to head aggregates of the filaments. In these experiments the samples 
were usually dialyzed for 30 min and analyzed immediately. 
Myosin-II filament formation was assayed quantitatively by sedimentation in 
a Beckman Airfuge (Beckman Instruments, Inc., Fullerton, CA). Samples of 150- 
170/tl were centrifuged at 23 psi (g average =  105,000) for 15 min. Aliquots of 
90/.d were removed from the meniscus, diluted with 500 gl of 0.5 M KCI and the 
myosin concentration  measured by absorbance at 230 nm. The extinction coef- 
ficient  at  230  nm  is  3.30D.ml/mg.  Consequently,  after dilution  a  sample 
containing  100 ~g  myosin-II/ml  has  an absorbance of 0.043.  Although this 
absorbance is low, it was possible with careful pipetting to measure reproducibly 
supernatant myosin-II concentrations  in the 10-50 gg/ml range. 
Specimens were prepared for electron microscopy by negative staining. Sam- 
pies of 5 gl containing 100 gg/ml myosin-II were placed on glow-discharged 
carbon coated grids for 30 s, drained by touching the edge of the grid to filter 
paper, reverted onto a drop of buffer for 5 s, drained, inverted on a drop of 1% 
aqueous uranyl acetate for 15 s, drained and air dried using suction through a 
Pasteur pipette with a constricted tip to remove any excess stain. Alternatively, 
pellets of filaments were fixed for 30 min at room temperature with  100 mM 
gtutaraldehyde, 2  mg/ml tannic acid in  10 mM  MgCI~,  20 mM  KC1,  10 mM 
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imidazote pH 6.8, washed, treated with 4 mM OsO4 in 50 mM KC1, 5 mM MgC12 
100 mM phosphate buffer, pH 6.0 at room temperature for 20 rain, dehydrated, 
and embedded. Micrographs were taken on a JE01  100 CX electron microscope 
at 33,000 or 50,000 magnification. The microscope was calibrated with negatively 
stained tropomyosin paracrystals. Filament widths were measured to the nearest 
0.1 mm on prints enlarged 2.5x using a lupe with a reticle. Bare zone and total 
lengths were measured to the nearest mm with a ruler or digitizer. 
RESULTS 
Like other myosins, the size of myosin-lI filaments depends on 
the solution conditions. Generally the filaments fall into one of 
two extreme classes: thin bipolar filaments composed of ~ 16 
molecules and  thick  filaments  that  are  formed  rapidly and 
reversibly by the lateral aggregation of the thin filaments. I will 
first describe the structure of the two major filament types and 
then, quantitative studies of the polymerization reaction and a 
detailed  survey  of  how  solution  conditions  affect  filament 
structure. The experiments were done with myosin-II with 0.8- 
4.9 heavy chain phosphates per molecule to evaluate the effect 
of phosphorylation on filament formation. This is the range of 
phosphorylation  that  affects  the  actin-activated  myosin-II 
ATPase (6). 
Structure of Myosin-II Filaments 
The size of the myosin-II molecule (Fig.  1 b) has been re- 
examined using the replicas from the previous study (29), but 
with special care to obtain the absolute length of the tail. This 
was done  by recording micrographs of the  molecules and  a 
tropomyosin paracrystal standard without changing lens cur- 
rent.  The  tail lengths had  a  Gaussian distribution (Fig.  l g) 
with a mean of 86 nm (SD  12 nm). 
In 20  mM  KC1  at pH 6.8  myosin-II filaments are bipolar 
with a central bare zone like other myosin filaments, but they 
are remarkable because they are exceedingly small and, like 
other cytoplasmic myosin filaments, very uniform in size (Fig. 
1;  Table  I).  The  overall length  is  -200  nm.  The  bare zone 
measures -6 nm wide in its center (Fig. 2; Table I). Although 
the variation in the measured width is small (SD 15%), this is 
probably an underestimate of the true width due to stain piling 
up around these thin myosin-II filaments. The mean length of 
the bare zone (the distance between the first globular projec- 
tions  cn  either  side)  is  -90  nm  and  the  variation  in  this 
dimension is considerably larger than the other two dimensions 
(SD  20%).  Globular material,  presumably myosin  heads,  is 
present at both ends of the filaments. In many cases the heads 
are clumped together, but in well stained specimens the heads 
are occasionally spread well enough to be resolved. Up to  12 
heads have been counted at one end.  Because each molecule 
has two heads, the thin myosin-II filaments must be composed 
of at least 12 myosin-II molecules. In the best cases (Fig. I c) 
the  two  heads  of individual myosin molecules can  be  seen 
attached to the filament backbone by stubby projections ~ 10 
nm long. There are one or two myosin-II molecules visible at 
any longitudinal position along the backbone. The spacing of 
these rows of heads is not regular, but is on the order of 15-20 
rim. 
In 10 mM MgC12, 20 mM KC1 at pH 6.8 myosin-II filaments 
are much thicker than in KCI alone (Figs. 2 and 3).  Like the 
thin  myosin-II filaments,  most  of these  thick  filaments  are 
bipolar with a  central bare zone and  globular projections at 
both ends.  Compared with the thin myosin-II filaments, the 
thick myosin-II filaments are much more variable in size and 
shape (Figs. 2 and 3; Table I). Their mean length is -250-300 
nm. The bare zone is -90 nm long and  -15 nm wide with a 
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Effect of Solution Conditions and Heavy Chain 
Phosphorylation  on Myosin-I/Filament Dimensions 
Bare zone width, mean (SD), nm 
Conditions  Po =  0.8  PQ =  2.6  Po =  4.9 
20 mM KCI,  pH 6.8  5.8 (0.5)  5.8  (0.6)  6.5  (0.8) 
20  mM  KCl,  10  mM  MgCI~,  17.5 (3.4)  15.8 (3.2)  15.2  (2.7) 
pH 6.8 
100 mM  KCl, 10 mM MgCl2,  9.6 (2.7)  8.9 (3.2)  9.9 (2.7) 
pH 6.8 
20  mM  KCI,  0.1  mM  EGTA,  6.5 (0.9)  6.9 (1.2)  -- 
0.5 raM, ATP,  pH 6.8 
20  mM  KCl,  10  mM  MgCl2,  16.7 (4.5)  14.0 (4.5)  -- 
0.1  mM  EGTA,  0.5  mM 
ATP,  pH 6.8 
Po is phosphate content in moles per mole. 
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EIGURE  2  Histograms  of  the  size  distributions  of  the  myosin-II 
filament  bare  zone widths  measured  on  electron  micrographs  of 
negatively stained specimens. Phosphorylation: ( A and  C) 0.8 phos- 
phates per molecule; ( B and  D) 2.6 phosphates per molecule. Buffer 
composition:  ( A  and  B) 20 mM KCl, 10 mM imidazole, pH 6.8;  ( C 
and  D) 20 mM KCI,  10 mM MgCI2, 10 mM imidazole, pH 6.8. 
FIGURE  1  Electron  micrographs of a  myosin-II  molecule and  thin 
filaments.  (a,  c-f)  Negatively stained filaments formed  in 20 mM 
KCl, 10 mM imidazole, pH 6.8 alone (a), with  1 mM  EDTA  (c)  or 
with 1 mM MgCI2 (d-f).  Individual myosin heads are marked with 
arrowheads in  c-f. (b) A shadowed myosin-II molecule for compar- 
ison with the filaments. Note that the shadow gives the illusion that 
the tail is thicker than in reality (2 nm). (g)  Histograms showing the 
size distribution of the myosin-II tail length, thin filament bare zone 
length and thin filament total length. Phosphorylation: ( a, e, and  f) 
1.5 phosphates per molecule; ( c, d) 0.8 phosphates per molecule, a, 
x  105,000;  b-f, x  155,000. 
considerable variation (Fig. 2). The pattern of spreading of the 
myosin-II heads  is  variable from  fdament  to  fdament  even 
within a single field. This is due, at least in part, to variability 
in the staining. For example, in Fig. 3 b  one filament is posi- 
tively stained,  two  are  negatively stained with  the  heads  in 
bulbous  clumps  and  one  is  negatively  stained  with  many 
individual heads clearly resolved. Other examples of clumped 
heads are shown in Fig. 3j and k. Even when the filaments are 
well spread and  stained it is impossible to resolve all of the 
myosin heads at the ends of these thick filaments, but up to 35 
have been counted at one end. Therefore, the thick myosin-II 
filaments must be composed of at least 35 myosin molecules. 
More  than  half  of the  thick  myosin-II  fdaments  have  a 
tightly-packed bare zone with parallel sides and discrete ends 
like that illustrated in Fig. 3 c, but many of these thick fdaments 
are not as well formed as illustrated in Fig. 3 d-i. In many cases 
the bare zone is skewed and runs diagonally across the filament 
(Fig. 3 e and g). The bare zone defects are generally oriented 
longitudinally and include splits near one end (Fig. 3 d), clefts 
in the center (Fig. 3 h) and apparent fragmentation into thinner 
filaments  (Fig.  3i).  These  defects  suggested  that  the  thick 
filaments might be composed of smaller subunits about the size 
of the thin myosin-II filaments. 
Cross sections of thick myosin-II filaments in pellets which 
were  embedded  and  sectioned  showed  that  the  bare  zone 
profiles are rounded.  Some of the  thickest filaments stained 
irregularly, suggesting a  subunit  structure,  but  details of the 
substructure have not yet been resolved. 
The possibility  that the thick myosin-II fdaments are formed 
by lateral aggregation of thin myosin-II fdaments was tested in 
two ways.  First, thin myosin-II filaments were formed in 20 
mM KC1 at pH 6.8 and then  10 mM MgCI2 was added. After 
818  THE  JOURNAL OF  CELL BIOLOGY.  VOLUME 95,  1982 FIGUR[  3  Electron  micrographs  of  negatively stained  myosin-II  thick  filaments  formed  in  20 mM  KCI,  10  mM  MgCIz,  10  mM 
imidazole,  pH  6.8.  Phosphorylation:  (a-i)  0.8  phosphates  per  molecule:  (j  and  k)  2.6  phosphates  per  molecule.  The  15-nm 
periodicity of the side arms is indicated in  (j)  and  (k).  a and  b, x  105,000;  c-h, x  155,000. 
60  s  in  10  mM  MgCh  the  thin  myosin-II  filaments  were 
converted  quantitatively  into  thick  filaments  with  the  same 
size, shape, and range of  longitudinal defects found in fdaments 
formed by dialysis of myosin-II in 0.5 M KCI (_10 mM MgC12) 
against 20 mM  KCI,  10 mM MgCI~ at pH 6.8 for 5-60 min 
(Fig. 4a). Second, thick myosin-II filaments formed in 20 mM 
KC1,  10  mM  MgC12 at  pH  6.8  were  adsorbed  to  electron 
microscope grids and  then  washed  on the  grid with  20 mM 
KCI, 0.2 mM EDTA. Within  5 s the thick fdaments start to 
break up longitudinally into thin bipolar thin filaments (Fig. 
4 b). This fragmentation is complete within  15 s, although the 
heads remain aggregated, holding the thin myosin-II fdaments 
in loose bundles. Together, these experiments indicate that the 
thick  filaments  are  formed  rapidly  and  reversibly by lateral 
aggregation of thin fdaments. 
Quantitative Analysis of the 
Polymerization Process 
The extent of polymerization was measured by sedimenta- 
tion in  an Airfuge.  At 23  psi  (105,000  g  average) myosin-II 
monomers in 0.5 M KC1 sediment out of the upper 60% of the 
sample  at  a  rate  of 0.4%  per  mmute.  This  corresponds to  a 
sedimentation coefficient of about 6S as expected for myosin- 
II (29).  Both myosin-II thin  filaments  (in  20 mM KCI) and 
thick  fdaments  (in  20 mM KC1,  10 mM MgCI2, are  cleared 
from the top 60% of the airfuge tube in < 15 min,  leaving a 
slowly sedimenting species,  presumably monomer or dimer, in 
the supematant.  Thus, during the  15-min centrifugation used 
to assay polymerization,  all  of the polymer and  ~6% of the 
slowly sedimenting species are removed from the supernatant 
(monomer)  fraction.  No correction was  made  for this  small 
monomer loss. All of the assays reported here were done using 
absorbance at 230 nm to measure the concentration of myosin- 
II in the monomer fraction, but identical results were obtained 
in control experiments  using the  Bradford (1)  protein  assay. 
Other control experiments established that there was no loss of 
myosin-II from the monomer fraction due to adsorption to the 
centrifuge tubes. 
The  extent  of myosin-II filament  formation  depends  on 
myosin-II concentration and  the  solution  conditions  (Fig.  5; 
Table II; following sections). No myosin-II pellets at very low 
total  myosin  concentrations  (< 15  #g/ml)  under  any  of the 
conditions  tested.  At  a  critical  concentration  (which  varies 
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of myosin-II  thin filaments and thick filaments.  (a) Thin filaments 
were formed  in  20  mM  KCI,  10  mM  imidazole, pH  6.8,  and  then 
MgCI2 was added to a concentration of 10 mM for 60 s before this 
specimen was prepared. (b) Thick filaments were formed in 20 mM 
KCI,  10  mM  MgCI2,  10 mM  imidazole, pH  6.8,  applied to the  EM 
grid  and  then  washed  with  three  drops  of  20  mM  KCI,  0.2  mM 
EDTA,  10 mM imidazole, pH 6.8 over a period of 15 s when the grid 
was stained. Phosphorylation: (a) 1.5 phosphates per molecule, (b) 
0.8 phosphates per molecule, x  105,000. 
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FIGURE  5  Dependence of  myosin-II  monomer (Cm)  and  polymer 
(Cp)  concentrations on the total myosin-II concentration (G). Con- 
ditions: All samples had 20 mM KCI, 10 mM imidazole, pH 6.8. Some 
samples  (O,  O)  also  contained  10  mM  MgCI2.  Phosphory[ation: 
major plot 2.6  phosphates  per molecule; inset 0.8 phosphates  per 
motecule. Filled symbols,  Co; open symbols,  Cm. 
slightly with  the  conditions)  filaments form  and  above this 
concentration the amount of filament formed is a linear func- 
tion of the myosin concentration. 
In 20 mM KC1,  10 mM MgCI2  10 mM imidazole (pH 6.8) 
myosin-II forms thick filaments and above a critical concentra- 
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TABLE  II 
Effect of Solution Conditions and Heavy Chain 
Phosphorylation on Myosin-II Polymerization Parameters 
Phos-  Critical 
Prepara-  phoryla-  concentra-  Slope  Co 
tion  Conditions  tion  tion  vs.  G 
moles/mole  #g/ml 
AM-58  20 mM KCI  1.5  30  0.83 
20  mM  KCI,  10  1.5  35  1.08 
mM MgCI2 
AM-60  20 mM KCI  2.6  24, 32  0.83 
20 mM KCI  0.8  19  0.63 
20  mM  KCl,  10  2.6  14, 18, 15  0.96,  0.93, 
mM MgCI2  0.89 
20  mM  KCI,  10  0.8  18  0.91 
mM MgCI2 
80  mM  KC[,  30  2.6  20, 15  0.73, 0.71 
mM MgCl2 
80  mM  KCI,  10  0.8  29  0.53 
mM MgCI2 
140  mM  KCl,  10  2.6  26  0.52 
mM MgCI2 
AM-64  20 mM KCI  4.9  16  0.83 
20  mM  KCI,  10  4.9  <5  1.0 
mM MgCl2 
tion of ~ 15 vg/ml the slope of the plot of myosin sedimented 
vs. total myosin is ~ 1 (Fig. 5, Table II), indicating that above 
the  critical concentration, the  same concentration of myosin 
monomer  is  in  equilibrium  with  polymer.  When  the  same 
experiment is carried out in 20 mM KCI at pH 6.8, conditions 
in  which  thin  myosin-II filaments  form,  there  is  a  critical 
concentration for polymerization, but above this critical con- 
centration the slope of a plot of polymer concentration vs. total 
concentration is <1  (Fig. 5). 
Effect of Solution Conditions on 
Filament Formation 
DIVALENT  CATIONS"  In the absence of divalent cations 
(1 mM EDTA) in 20 mM KC1 at pH 6.8 myosin-II forms thin 
filaments indistinguishable in size and shape from those in 20 
mM KCI without EDTA  (Fig.  1 c)  so that traces of divalent 
cations  are  not  required  for  polymerization.  MgCh  in  the 
millimolar range  causes  a  concentration-dependent aggrega- 
tion of thin myosin-II filaments (Fig.  1) into thick filaments 
(Fig. 3). This can be assessed by both electron microscopy and 
a  5-rain sedimentation assay (Fig. 6),  because the thick fila- 
ments sediment somewhat more rapidly than the thin filaments. 
In 1 mM MgCI2 (Fig. I d and f)  the filaments are identical to 
those  in  1  mM  EDTA.  The  transition  from  thin  to  thick 
filaments is smooth and has a midpoint at 4-5 mM MgCI2.  At 
these intermediate concentrations of MgCh the filaments are 
heterogeneous in size, as indicated by the large standard devia- 
tions  in  bare  zone  width  (Fig.  6).  Many  are  typical  thin 
filaments, some of which are loosely associated in lateral pairs 
as if caught in the act of aggregating, but some of the filaments 
are intermediate in size between thin and thick filaments. 
All of the divalent cations tested (Ca  ++, Mn  ++, Co  ++, Cu  ++, 
Zn  ++) at a concentration of 10 mM gave thick filaments very 
similar to those formed in  10 mM  MgC12. In particular, the 
mean bare width was  14-18 nm  and there were longitudinal 
clefts in  many  bare zones.  In the  two  different preparations 
polymerized  in  10  mM  CaCI~  the  myosin-II  heads  were clumped and ordered enough to give a  16-nm axial periodicity 
(Fig. 7a).  In single preparations, none of the other divalent 
cations gave this periodicity. 
SALT  CONCENTRATION"  Concentrations  of  KC1  >20 
mM inhibit both the extent of myosin-II polymerization and 
the divalent-cation-induced aggregation of thin myosin-II fil- 
aments to form thick t'daments. The dependence of polymer 
concentration  on  KC1  concentration  is  very  similar  in  the 
presence  of  10  mM  MgC12 (Fig.  8)  or  in  its  absence  (not 
illustrated). Between 20 and 150 mM KC1 the polymer concen- 
tration falls and at or above 200 mM KCI there are no filaments 
detectable by electron microscopy. In the absence of MgCI2, 
this inhibition of polymerization by KC1 takes place without 
any effect on the size or shape of the filaments that do form 
(Fig. 9). Thus, up to the point at which no t'daments form, the 
salt concentration has no obvious effect on thin filament struc- 
ture. In 10 mM MgClz, at pH 6.8 normal thick filaments form 
in 20-80 mM KCI. In 100 mM KC1,  10 mM MgCI2 there is a 
high  proportion  of  thin  filaments  and  the  thick  filaments 
present are thinner than those at lower KCI concentrations. In 
140 mM KCI,  10 mM MgC12 only thin filaments form. As in 
the absence of MgCI2, no fdaments form in KCI concentrations 
200 mM (Fig. 9). 
In the case of muscle myosin at pH 8.0-8.5 (18, 19) inhibition 
of polymerization, as observed here by KC1, is caused by an 
increase in the critical concentration. In contrast, with myosin- 
II the critical concentration is very low even in  140 mM KCI 
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FIGURE  6  Dependence of myosin-I/  filament  size on  the concen- 
tration of MgCI2. Size was measured indirectly by a 5-rain centrifu- 
gation  in  a  Beckman  Airfuge  (Beckman  Instruments,  Inc.)  which 
pellets all of the thick filaments and about half of the skin filaments 
(O).  Bare zone width  (mean •  _  SD)  was measured directly from 
electron  micrographs.  Phosphorylation:  1.5  phosphates  per  mole- 
cule. 
and varies to only a small extent as a function of KC1 concen- 
tration (Fig.  10; Table II). Instead the KC1 concentration has 
a large effect on the fraction of myosin-II polymerized above 
this relatively constant critical concentration. This gives plots 
of polymer concentration (Cp) vs total myosin concentration 
(Ct) with slopes <1 (Fig. 10) under inhibitory conditions. The 
slope of a  Co vs.  Ct plot is inversely proportional to the KCI 
concentration (Table II). The large fraction of myosin-II in the 
140  mM  KCI supernatant  is not due to small filaments that 
sediment slowly. After  10  min  of ultracentrifugation (which 
pellets the filaments) the myosin-II in the supernatants sedi- 
0  0.1  0.2  0.3  0.4  0.5 
KCI, M 
FIGURE  8  Inhibition  of 
myosin-II  polymerization 
by KCI. Polymer concentra- 
tion was measured by pel- 
leting.  The  percent  poly- 
mer  was  calculated  after 
subtracting the critical con- 
centration  in  20  mM  KCI 
(25  p.g/ml)  from  the  total 
myosin-II  concentration 
(100  .ug/ml),  such  that 
100%  is  the  polymer concentration  in  20  mM  KCI.  In  addition  to 
variable  concentrations  of  KCI  the  solutions  contained  10  mM 
MgCl2,  10  mM  imidazole, pH  6.8.  Phosphorylation:  (O), 0.8 phos- 
phates  per  molecule;  (0)  2.6  phosphates  per  molecule;  (1-1) 4.9 
phosphates per molecule. Values plotted are means of three sepa- 
rate determinations. 
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FIGURE  9  Effect of KCI concentration on  myosin-II filament struc- 
ture.  Plot of  mean bare zone width  (+1  SD)  as a  function  of  KCl 
concentration. Conditions: 10 mM imidazole, pH 6.8 with  (0) vary- 
ing KCI  alone or (O)  varying KCI with 10 mM MgCI2.  Phosphoryla- 
tion: 1.5 phosphates per molecule. 
FIGURE  7  Electron  micrographs  of  myosin-II  filaments  formed  in  20  mM  KCI,  10  mM  CaCI2,  10  mM  imidazole,  ptl  6.8. 
Phosphorylation:  (a) 2.6 phosphates per molecule; (b) 0.8 phosphates per molecule. The 15-nm  periodicity of the clumped  heads 
is indicated  in  (a). x  105,000. 
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F~GURe 10  Dependence of myosin-ll polymer concentration (Cp) 
on the total myosin-II concentration (G). Conditions: 10 mM MgCI2, 
10 mM imidazole, pH 6.8 with  (O) 20 mM KC[, (A, A) 80 mM KC[, 
(I~) 140 mM KCI.  Phosphorylation: open symbols 2.6 phosphates per 
molecule; closed triangles 0.8 phosphates per molecule. 
merits no faster than monomer and no filaments are detectable 
in the negatively stained samples. The fraction of unpolymer- 
ized myosin-II in the  140 mM KCI,  10 mM MgCb (pH 6.8) 
supernatant is competent to polymerize and forms normal thick 
filaments after 30 min dialysis vs. 20 mM KC1,  10 mM MgC12 
at pH 6.8. 
KC1 is the only salt examined in any detail, but inhibition of 
polymerization is not limited to KC1. Sodium pyrophosphate 
inhibits myosin-II polymerization at concentrations about  10 
times lower than KC1, just as it does with muscle myosin (14). 
pH:  At pH 8 myosin-II forms typical thin myosin-II fila- 
ments (Fig.  11 a  and c). At pH 6 myosin-II forms thick illa- 
ments (mean width,  16.2 rim, SD 6.7 nm), which have an even 
stronger tendency to aggregate in clumps (Fig. 11 b) than in 10 
mM CaCb. Many of these filaments have the heads clumped 
in rows at 15-nm intervals. 
ATP:  The presence of 0.5  mM ATP has no effect on the 
morphology of myosin-II filaments.  In 20 mM  KCI, typical 
thin myosin-II filaments form in the absence of MgCI2 (Fig. 
12a)  and  typical thick  filaments  form in the  presence  of 10 
mM MgCh (Fig. 12b). 
Effect of Heavy Chain Phosphorylation  on 
Myosin-II Polymerization 
Myosin-II has  three  phosphorylation sites  on  each  heavy 
chain, all located near the C-terminal end of the polypeptide 
within  4-5  nm of the  tip  of the  tail  (5,  8).  My preparations 
isolated by the method of Pollard et al. (29) had 1.5-2.6 moles 
phosphate per mole of myosin. After dephosphorylation with 
potato acid phosphatase,  the phosphate content was reduced 
to 0.8  moles per mole myosin. Dephosphorylation increased 
the  Ca  ++  ATPase-specific  activity  about  twofold.  After  de- 
phosphorylation the actin-activated Mg  ÷+ ATPase (0.2 mg/ml 
Acanthamoeba actin,  7.5  mM MgCb 0.5  mM ATP,  0.1  mM 
CaCh, 6 mM KC1, 5 mM imidazole, pH 7, at 29°C) was 240 
nmoles.min-l.mg  -1.  In one preparation actin and myosin-II 
were precipitated by dialysis of the DEAE fractions against 5 
mM MgC12 0.25  mM dithiothreitol,  20 mM imidazole, pH 7, 
instead of the usual hexakinase-glucose treatment. This yielded 
myosin-II with 4.9 phosphates per mole. 
In the range of 0.8-4.9 phosphates per myosin-II, the extent 
of phosphorylation had no effect on the size of the filaments 
formed at pH 6.8 in 20 mM or 100 mM KC1, _+10 mM MgCI2, 
+_0.5 mM ATP (Table I, Fig. 2). Furthermore, myosin-II with 
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FIGURE 11  Effect  of  pH  on  myosin-ll  filaments.  (a,  b)  Electron 
micrographs of  negatively stained  filaments.  Conditions:  20  mM 
KCI, 10 mM imidazole at {a) pH 8.0 or (b) pH 6.0. (c) Histograms of 
the bare zone width distributions as a function of pH. Phosphoryl- 
ation: 0.8 phosphates per molecule, x  105,000. 
2.6 or 0.8 phosphates per molecule produced similar filaments 
over the pH range of 6-8 and in 10 mM concentrations of the 
various divalent cations tested. The only morphological differ- 
ences noted were a  much stronger tendency of the phospho- 
rylated  myosin-II thick  filaments  to  aggregate  end  to  end 
(compare Fig. 7 a and b) and for their heads to clump near the 
filament backbone (Fig. 3j and k). In 10 mM divalent cations, 
dephosphorylated myosin-II thick  filaments  were aggregated 
on only one out of seven grids examined, and the myosin heads 
were almost always well spread from the backbone regardless 
of the solution conditions (Figs.  3 a-i,  7b,  12b).  In contrast, 
thick  filaments  made  from  myosin-II which  had  not  been 
treated with acid phosphatase were aggregated end to end on 
9 out of 11 grids. 
In the quantitative assays for polymerization, extent ofphos- 
phorylation had only small effects on the critical concentration 
(Table  II). When compared directly in the same experiment, 
dephosphorylated  myosin-II was  slightly  more  sensitive  to ~.  20Ohm  "l  FIGURE  13  Drawings of mod- 
k~  90nm~  els  of  myosin-II  thin  fila- 
~,~ ~  i~ll  ~:  =  ~II'  ~  I/°~  ments. The upper drawing (a) 
6nm  1151  is  a  two-dimensional  scale  a 
drawing with the approximate 
~'~'  ~'~1~  dimensions.  The  total  length 
"ql~l'~dlDdll  ~I~ ~Ib  (200 nm)  is greater  than (6 x 
15 nm)  +  90 nm  because the  b 
heads  add  -10  nm  to  each 
end.  Below (b)  is an exploded view showing the proposed  longi- 
tudinal positions of the 16 myosin-II molecules.  Nothing is known 
about the lateral associations. The lateral positions in the exploded 
view are arbitrary  and are not likely to be accurate. 
FIGURE 12  Electron micrographs  of myosin-II filaments formed  in 
0.5 mM ATP with 20 mM KCI, 10 mM imidazole, pH 6.8 alone (a) 
and with 10 mM MgCI2 and 0.1 mM EGTA (b). Phosphorylation: 0.8 
phosphates  per molecule, x  105,000. 
inhibition of polymerization by high KCI concentrations in l0 
mM MgC12 (Figs. 8 and 10; Table II). For example in Fig. 10, 
80 mM KCI inhibited the polymerization of myosin-II with 0.8 
phosphates as much as  140 mM KCI inhibited the myosin-II 
with 2.6 phosphates. Likewise, the slope of Cp vs. Ct plots in 20 
mM KC1 (Fig. 5; Table II) was less for dephosphorylated than 
phosphorylated myosin-II. On the other hand, there is variation 
in the slopes of these plots from one preparation to the next 
and my most highly phosphorylated sample (4.9  phosphates 
per molecule) behaved much like the dephosphorylated sample 
from another preparation (Fig. 8). 
DISCUSSION 
Structure of Thin Myosin-II  Filaments 
Electron micrographs of thin myosin-II filaments showing 
the  central bare  zone  and  globular projections at  both  ends 
clearly indicate that the myosin-II molecules are in a  bipolar, 
antiparallel arrangement like other myosin filaments. Further- 
more these micrographs also contain enough  information  to 
determine the number of myosin molecules and their arrange- 
ment, at least in two dimensions. 
The  dimensions  of the  myosin-II molecule  and  the  thin 
myosin-II filament put substantial constraints on the number 
of molecules in the filaments. First, the filaments are slightly 
more than  twice as long as the  tail of the  molecule, so that 
except for the terminal myosins at each end, the tails of all of 
the  myosins  must  overlap  in  the  center  of the  bare  zone. 
Consequently,  the  maximum  number  of molecules in  a  thin 
myosin-II filament is established by the diameter of the bare 
zone. The observed diameter of 6-7  nm in the center of the 
bare zone is large enough to accommodate ~ 12 myosin tails in 
a hexagonal array with center to center spacing of 2 nm and no 
central hole (27). Second, the heads at the two ends of the thick 
filaments are arranged in rows spaced at intervals of 15-16 nm 
(Figs. 3j and k, 7a,  l I b). I assume that the same is true of the 
thin filaments. Given the length of the filament (200 nm) and 
bare  zone  (90  nm),  there  are  four  rows  of heads  at  15-nm 
intervals at each end (Fig.  13). The difficult question is, how 
many molecules are there in each row?. There could be one, 
giving a total of eight molecules per thin filament. This model 
is inconsistent with three observations: (a) the  bare zone di- 
ameter of an 8-molecule filament would be only 5.2 nm; (b) 
there are up to 12 globular projections at one end (Fig. 1); and 
(c) two Y-shaped projections are seen directly in some rows 
(Fig.  I c  and f).  On  the  other hand,  these  observations are 
consistent with four rows of two molecules each at both ends 
(Fig. 13). Such a filament should have a bare zone diameter of 
7.8  am,  which  is  well within  the  experimental error  of the 
measurements of bare zone width, which probably underesti- 
mate the true diameter due to shrinkage and piling up of stain. 
If there were three or four molecules per row the  bare zone 
would have a diameter of 9.6 or 11 nm, which is well beyond 
the estimate made by electron microscopy. Consequently, the 
electron micrographs support best a model for the thin filament 
with  16 myosin-II molecules arranged as shown in Fig. 13 a. 
In the model of the thin myosin-II filaments the tails of the 
myosin-II molecules flanking the bare zone extend fully across 
the  bare  zone  and  those  in  the  fourth  rows  come  close  to 
touching end to end, but do not overlap, in the middle of the 
bare zone. Consequently there are 14 tails in the center of the 
bare zone and l0 at the edges of the bare zones, accounting for 
the  slight taper  in  the  bare  zone  diameter  observed  in  the 
electron micrographs. The model is drawn in two dimensions 
because nothing is yet known about the (presumably helical) 
arrangement of the molecules. Given the plane of symmetry in 
the center of the  bare zone  and the presumed twofold axial 
symmetry, there are only four unique myosin positions in these 
simple filaments. 
The exploded view (13 b) illustrates the proposed longitudi- 
nal stagger of the  l0 myosin-II molecules, but is not meant to 
indicate  anything  regarding  the  lateral  associations  about 
which  nothing is known.  This  exploded view makes it clear 
that the myosin-II thin filaments cannot be composed of par- 
allel dimers with a 43 nm stagger, which are thought to be the 
building blocks of muscle myosin filaments (2,  l l). Note also 
that except for the four myosin-II molecules flanking the bare 
zone, the  heads  are not  located near the ends  of any of the 
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the end of the tail (5) would not appear to be in a position to 
interact directly with heads and to influence the ATPase activ- 
ity when the myosin-II is polymerized. 
It  is  interesting  that  the  skeletal  muscle  myosin  "mini- 
filaments" which form in 10 mM citrate/Tris buffer at pH 8.0 
are also composed of 16 myosin molecules (30). The arrange- 
ment of the  16 amoeba or muscle myosin molecules in these 
small filaments is probably an especially stable configuration 
with limited potential for further elongation. 
The micrographs of the filaments also give some indication 
about  the  segmental  flexibility  of the  myosin-II molecule. 
Many well preserved myosin-II filaments have clearly resolved 
side arms, some of which are Y-shaped. Presumably the arms 
of the Y are the heads, whereas the base of the Y is comparable 
to muscle myosin subfragment-2, which links the heads to the 
light  meromyosin backbone  of muscle  thick  fdaments  (22). 
Many of these side arms are perpendicular to the backbone, so 
at least after drying there can be a 90  ° bend in the myosin-II 
tail  at  the  point  where  the  side  arm  bends  away  from the 
backbone. 
Compared with the subfragment-2 region of skeletal muscle 
myosin, which is  ~50 nm long (22)  and  allows the heads to 
spread up to 60 am from the filament backbone (28,  35) the 
corresponding region of the myosin-II tail is quite short. The 
myosin-II side arms project only 20 nm from the backbone. 
Given that the heads are ~ 10 nm long the linker region is no 
more than 10 nm long. This conclusion is consistent with direct 
observation of the linker region of individually resolved side 
arms which is also <10 nm long (Fig.  1). This suggests that a 
major part of the difference in the length of the tails of myosin- 
II and muscle  myosin could be due  to the  almost complete 
absence in myosin-II of a region comparable to skeletal muscle 
myosin  subfragment-2.  If the  subfragment-2  region  of the 
myosin-II tail  is  <10  nm  long,  the  remaining  part  of the 
myosin-II tail is exactly the same length as muscle myosin light 
meromyosin (80 nm; reference 22). The idea that the myosin- 
II tail is all or mostly equivalent to muscle light meromyosin 
is supported circumstantially by two independent observations. 
First, the rows of myosin-II molecules in the backbone of the 
filament are staggered by l 5 am. In muscle thick filaments the 
15-nm spacing is determined by the properties of light mero- 
myosin. Second, there are no sensitive proteolytic cleavage sites 
within  the tail  of the myosin-II molecule (5).  In the muscle 
myosin tail there are, of course, two such sensitive sites, located 
at the two ends of the subfragment-2 region (22). 
Structure of Thick Myosin-II Filaments 
The thick myosin-II filaments are much more complex than 
the thin filaments.  So far it has been impossible to ascertain 
their structure by electron microscopy. Their diameter is vari- 
able and many are imperfectly formed. The longitudinal clefts 
in  the  defective thick  filaments  arid  the  demonstration  that 
thick and thin filaments are interconvertible in a few seconds 
by simple changes in the ionic conditions, both argue that the 
thick filaments are formed by the lateral  aggregation of thin 
filaments. The diameter of the thick fdaments is large enough 
to accommodate 3-6 thin filaments, but unfortunately subunits 
have  not  yet  been  resolved  in  cross  sections  of the  thick 
filaments,  so that the number and packing of the constituent 
thin filaments is unknown. 
Accepting  the  interpretation  that  the  thick  filaments  are 
composed of thin  filaments,  there  are two observations that 
suggest that the thin filaments comprising the thick filaments 
are not in perfect longitudinal register, but rather are staggered 
longitudinally by multiples of 15 rim. First, many of the thick 
fdaments have skewed bare zones or bare zones with indistinct 
margins (Fig. 3).  Second, the overall length of the thick illa- 
ments (300 am) is 50% greater than the thin filaments. In spite 
of this longitudinal displacement of  the thin filaments, the rows 
of myosin  heads  must  be  in  register,  because  many  thick 
filaments (especially in  10 mM CaCI2  and at pH 6) have the 
heads clumped in rows with a  15-am spacing (Fig. 7a). 
Mechanism  of Polymerization 
Myosin polymerization probably involves a number of dis- 
crete reversible steps including myosin dimerization, filament 
nucleation and elongation (10). In the case of myosin-II there 
is  also  lateral  aggregation  of thin  filaments  to  form  thick 
filaments.  A  quantitative  description  of the  polymerization 
mechanism will require identification of the reaction pathway 
and measurement of the kinetic constants for each step. In no 
case has this been completed, but for muscle myosin Davis (10) 
has used pressure-jump experiments to show that elongation is 
very fast, probably diffusion-limited, and that dissociation rates 
vary by a  factor of 500 depending on filament length.  Thus 
polymer length  is  controlled  kinetically  by the  dissociation 
reaction. 
At  equilibrium  myosin polymerization  systems  consist  of 
subunits,  which are  actually a  monomer-dimer equilibrium, 
and  polymer which,  in  the  case  of skeletal  muscle  myosin 
minifilaments (31) and the myosin-II filaments described, here 
have a very discrete size distribution.  The absence of species 
intermediate  in size between subunits and the polymer dem- 
onstrates the high cooperativity of the muscle  and Acantha- 
moeba myosin polymerization process. 
In the original quantitative analysis of  muscle myosin polym- 
erization, Josephs and Harrington (18) introduced as a simpli- 
fying assumption, that at equilibrium a skeletal muscle myosin 
polymerization system consists of only monomer and polymer. 
n.monomers ~  polymer 
K  =  Cp/fm  n 
K is the equilibrium constant, Cp is the polymer concentration, 
Cm  is  the  monomer concentration  and  n  is  the  number  of 
subunits in the polymer. The dependence of C  o on total myosin 
concentration,  Ct,  is determined  by the n  and  K.  For many 
values of n and K there is a critical concentration below which 
there is essentially no polymer and above which Cm is approx- 
imately constant. Model calculations show that when n is small 
the critical concentration is low and relatively independent of 
K. When K  is large the monomer-polymer transition around 
the critical concentration is sharp and the slope of Cp vs. Ct is 
1. When K  is small the transition from monomer to polymer 
is smooth and at low Cp the plot of Cp vs. Ct is curved and has 
a slope < 1. 
This  model must be  oversimplified judging from the  new 
work  of Davis  (10),  but  under  a  variety  of conditions  the 
behavior of muscle myosin agrees well with the model (18, 31). 
Over the limited range of concentrations tested Acanthamoeba 
myosin-II polymerization is  also consistent  with  this  model. 
The critical concentration for myosin-II polymerization is one 
or two orders of magnitude lower than for muscle myosin. This 
difference may be attributable, at least in part, to the small size 
of the myosin-II filaments rather than the myosin-II having a 
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the fact that plots of Co vs. Ct are < 1, under many conditions 
(Table II), suggests that the myosin-II equilibrium constant is 
relatively small, although the data are not yet extensive enough 
to calculate  meaningful  values  for the  equilibrium  constant, 
Smooth muscle myosin polymerization differs from both skel- 
etal muscle and Acanthamoeba myosin-II in having  neither a 
critical concentration nor a linear dependence of Cp on Ct (25), 
In every case more detailed  analysis  recognizing the various 
intermediates  in  the  myosin polymerization  reaction  will be 
required  to  understand  the  polymerization  mechanism.  The 
myosin-II polymerization reactions may be particularly ame- 
nable  to more detailed  analysis,  because  there  are only  four 
unique positions in the filaments and therefore a limited num- 
ber of reactions and intermediates. 
Form of Myosin-II in the Cell 
Because the concentration of myosin-ll in the cell is ~ 1 mg/ 
ml (29)  and  the  salt  concentration  is thought  to be low, the 
properties of myosin-II suggest that it should be almost com- 
pletely  polymerized in  the  cell.  The  exact  cytoplasmic  ionic 
conditions  are not known,  but  need  to be established  before 
further conclusions can be drawn. In addition it will be neces- 
sary to test for inhibitors  of myosin-II polymerization in the 
cell.  Regardless  of cytoplasmic conditions  and  the  extent  of 
myosin-II polymerization, it will  be very difficult  to identify 
cytoplasmic myosin-II filaments by electron microscopy of thin 
sections, because the filaments are so small. I hope that ultra- 
structural  localization  with  highly  specific  new  monoclonal 
antibodies (20) will help answer the questions about the form 
of myosin-II in the cell. 
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